Consolidated Statement Of Profit Or Loss

CHUGAI PHARMACEUTICAL CO., LTD. - Filing #7552407

Concept 2023-01-01 to
2023-06-30
2023-01-01 to
2023-06-30
2023-01-01 to
2023-06-30
2023-01-01 to
2023-06-30
2023-01-01 to
2023-06-30
2023-04-01 to
2023-06-30
2023-01-01 to
2023-06-30
2022-01-01 to
2022-06-30
2022-01-01 to
2022-06-30
2022-01-01 to
2022-06-30
2022-01-01 to
2022-06-30
2022-01-01 to
2022-06-30
2022-01-01 to
2022-06-30
2022-04-01 to
2022-06-30
Consolidated statement of profit or loss
Statement of profit or loss
Revenue
579,657,000,000 JPY
267,417,000,000 JPY
595,947,000,000 JPY
235,612,000,000 JPY
Cost of sales
242,990,000,000 JPY
91,662,000,000 JPY
194,247,000,000 JPY
79,823,000,000 JPY
Gross profit
336,667,000,000 JPY
175,756,000,000 JPY
401,700,000,000 JPY
155,789,000,000 JPY
Selling, general and administrative expenses
54,280,000,000 JPY
33,264,000,000 JPY
45,944,000,000 JPY
23,157,000,000 JPY
Other expenses
JPY
2,401,000,000 JPY
Operating profit (loss)
210,910,000,000 JPY
112,614,000,000 JPY
286,947,000,000 JPY
99,940,000,000 JPY
Finance costs
11,000,000 JPY
9,000,000 JPY
29,000,000 JPY
15,000,000 JPY
Profit (loss) before tax
213,656,000,000 JPY
113,994,000,000 JPY
286,918,000,000 JPY
100,713,000,000 JPY
Income tax expense
56,963,000,000 JPY
30,801,000,000 JPY
82,765,000,000 JPY
28,335,000,000 JPY
Profit (loss)
156,693,000,000 JPY
JPY
JPY
156,693,000,000 JPY
156,693,000,000 JPY
83,193,000,000 JPY
JPY
204,153,000,000 JPY
JPY
204,153,000,000 JPY
204,153,000,000 JPY
JPY
JPY
72,378,000,000 JPY
Profit (loss) attributable to
Owners of parent
156,693,000,000 JPY
83,193,000,000 JPY
204,153,000,000 JPY
72,378,000,000 JPY
Earnings (loss) per share
Basic earnings (loss) per share
95.25
50.57
124.14
44.00
Diluted earnings (loss) per share
95.23
50.56
124.08
43.99

Talk to a Data Expert

Have a question? We'll get back to you promptly.